| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |